Immunocore director granted 27,492 stock options
Immunocore Holdings plc director William Pao received a new stock option grant.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Immunocore Holdings plc director William Pao received a new stock option grant. The award covers 27,492 options to buy Ordinary Shares at an exercise price of $28.52 per share, expiring on May 26, 2036.
The options vest at the earlier of May 27, 2027, or the day immediately before Immunocore’s next annual general meeting, as long as Pao remains in continuous service through the vesting date. Following this grant, he holds 27,492 share options directly.
Insider Trade Summary
Grant/Award: 27,492 shares
Grant/Award
1 txn
Insider
Pao William
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option (Right to Buy) | 27,492 | $0.00 | $0.00 |
Holdings After Transaction:
Share Option (Right to Buy) — 27,492 contracts (Direct)
Holdings Before and After:
Share Option (Right to Buy), 0 to 27,492 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option award shall vest at the earlier of (i) May 27, 2027 and (ii) the day immediately prior to the date of the Issuer's next annual general meeting, subject to the Reporting Person's continuous service through such vesting date.
Key Figures
Options granted: 27,492 options
Exercise price: $28.52 per share
Expiration date: May 26, 2036
+2 more
5 metrics
Options granted
27,492 options
Grant to director William Pao on May 27, 2026
Exercise price
$28.52 per share
Share Option (Right to Buy) for Ordinary Shares
Expiration date
May 26, 2036
Option term end for granted share options
Vesting date
Earlier of May 27, 2027 or pre-AGM
Vesting contingent on continuous service
Post-grant derivative holdings
27,492 options
Total derivative securities following transaction
Key Terms
Share Option (Right to Buy), exercise price, vesting, annual general meeting, +1 more
5 terms
exercise price financial
"conversion_or_exercise_price: "28.5200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to the option award shall vest at the earlier of"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual general meeting financial
"the day immediately prior to the date of the Issuer's next annual general meeting"
derivative securities financial
"derivativeTransactionCount": 1"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Immunocore (IMCR) director William Pao report on this Form 4?
He reported receiving a grant of 27,492 stock options. These options give him the right to buy Immunocore Ordinary Shares at a fixed price, reflecting equity-based compensation rather than an open-market share purchase or sale.
How many Immunocore (IMCR) options were granted to William Pao and at what price?
William Pao was granted 27,492 share options with an exercise price of $28.52 per share. This means he can buy Immunocore Ordinary Shares at that fixed price once the options vest and before they expire.
When do William Pao’s Immunocore (IMCR) stock options vest?
The options vest on the earlier of May 27, 2027, or the day immediately before Immunocore’s next annual general meeting. Vesting is contingent on his continuous service with the company through the applicable vesting date.
When do the Immunocore (IMCR) options granted to William Pao expire?
The granted stock options expire on May 26, 2036. After this expiration date, any unexercised options will lapse, meaning they can no longer be used to purchase Immunocore Ordinary Shares at the stated exercise price.
How many Immunocore (IMCR) derivative securities does William Pao hold after this grant?
After this transaction, William Pao holds 27,492 derivative securities in the form of share options. These options represent the right to acquire an equivalent number of Immunocore Ordinary Shares upon exercise, subject to vesting and expiration terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
